These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 11031225)
1. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies. Pietzsch J; Lattke P; Julius U Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E63-7. PubMed ID: 11031225 [TBL] [Abstract][Full Text] [Related]
2. Different susceptibility to oxidation of proline and arginine residues of apolipoprotein B-100 among subspecies of low density lipoproteins. Pietzsch J; Julius U FEBS Lett; 2001 Feb; 491(1-2):123-6. PubMed ID: 11226433 [TBL] [Abstract][Full Text] [Related]
3. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach. Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585 [TBL] [Abstract][Full Text] [Related]
4. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998 [TBL] [Abstract][Full Text] [Related]
5. Glucose-induced enhancement of hemin-catalyzed LDL oxidation in vitro and in vivo. Julius U; Pietzsch J Antioxid Redox Signal; 2005; 7(11-12):1507-12. PubMed ID: 16356114 [TBL] [Abstract][Full Text] [Related]
6. Measurement of 5-hydroxy-2-aminovaleric acid as a specific marker of metal catalysed oxidation of proline and arginine residues of low density lipoprotein apolipoprotein B-100 in human atherosclerotic lesions. Pietzsch J; Bergmann R J Clin Pathol; 2003 Aug; 56(8):622-3. PubMed ID: 12890816 [TBL] [Abstract][Full Text] [Related]
7. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins. Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944 [TBL] [Abstract][Full Text] [Related]
8. Measurement of 5-hydroxy-2-aminovaleric acid as a specific marker of iron-mediated oxidation of proline and arginine side-chain residues of low-density lipoprotein apolipoprotein B-100. Pietzsch J Biochem Biophys Res Commun; 2000 Apr; 270(3):852-7. PubMed ID: 10772915 [TBL] [Abstract][Full Text] [Related]
9. Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100. Raungaard B; Heath F; Hansen PS; Brorholt-Petersen JU; Jensen HK; Faergeman O Clin Chem; 2000 Feb; 46(2):224-33. PubMed ID: 10657378 [TBL] [Abstract][Full Text] [Related]
10. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. Krul ES; Parhofer KG; Barrett PH; Wagner RD; Schonfeld G J Lipid Res; 1992 Jul; 33(7):1037-50. PubMed ID: 1431583 [TBL] [Abstract][Full Text] [Related]
11. Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs. Schaefer JR; Scharnagl H; Baumstark MW; Schweer H; Zech LA; Seyberth H; Winkler K; Steinmetz A; März W Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):348-53. PubMed ID: 9081691 [TBL] [Abstract][Full Text] [Related]
12. Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100. Stalenhoef AF; Defesche JC; Kleinveld HA; Demacker PN; Kastelein JJ Arterioscler Thromb; 1994 Mar; 14(3):489-93. PubMed ID: 8123657 [TBL] [Abstract][Full Text] [Related]
13. Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Ordovas JM; Schaefer EJ J Lipid Res; 1997 Aug; 38(8):1535-43. PubMed ID: 9300775 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred. Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645 [TBL] [Abstract][Full Text] [Related]
15. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Miserez AR; Keller U Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549 [TBL] [Abstract][Full Text] [Related]
16. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia. Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320 [TBL] [Abstract][Full Text] [Related]
17. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB. van der Hoek YY; Lingenhel A; Kraft HG; Defesche JC; Kastelein JJ; Utermann G J Clin Invest; 1997 May; 99(9):2269-73. PubMed ID: 9151801 [TBL] [Abstract][Full Text] [Related]
18. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro. Tertov VV; Sobenin IA; Kaplun VV; Orekhov AN Free Radic Res; 1998 Aug; 29(2):165-73. PubMed ID: 9790519 [TBL] [Abstract][Full Text] [Related]
19. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Pimstone SN; Defesche JC; Clee SM; Bakker HD; Hayden MR; Kastelein JJ Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944 [TBL] [Abstract][Full Text] [Related]
20. The binding of very low density lipoprotein remnants to the low density lipoprotein receptor in familial defective apolipoprotein B-100. Maher VM; Gallagher JJ; Myant NB Atherosclerosis; 1993 Aug; 102(1):51-61. PubMed ID: 8257452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]